Newsoara Biopharma 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Products    Trials    News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
ZEN-3694 / Zenith Capital Corp           
          
            
             
olvimulogene nanivacirepvec (GL-ONC1) / Genelux           
          
            
             
AUM001 / AUM Biosci           
          
            
             
HPP737 / vTv Therapeutics